ADMA Biologics (ADMA) Short Interest Ratio & Short Volume

ADMA Biologics logo
$13.16 -0.32 (-2.34%)
As of 11:44 AM Eastern
This is a fair market value price provided by Massive. Learn more.

ADMA Biologics Short Interest Overview

As of October 30, 2026, ADMA Biologics (ADMA) had a short interest of 18.04 million shares sold short, representing 8.38% of the public float. This marks a 7.65% decrease in short interest since the prior report. The short interest ratio (days to cover) is 7.1, meaning it would take 7.1 days of the average trading volume of 4.14 million shares to cover all short positions.

Current Short Interest
18,035,119 shares
Previous Short Interest
19,528,063 shares
Change Vs. Previous Report
-7.65%
Dollar Volume Sold Short
$205.78 million
Short Interest Ratio
7.1 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
221,854,000 shares
Short Percent of Float
8.38%
Today's Trading Volume
566,348 shares
Average Trading Volume
4,139,873 shares
Today's Volume Vs. Average
14%
Short Selling ADMA Biologics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for ADMA Biologics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

ADMA Short Interest Over Time

ADMA Days to Cover Over Time

ADMA Percentage of Float Shorted Over Time

ADMA Biologics Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/202618,035,119 shares $205.78 million -7.7%8.4%7.11 $11.41
10/15/202619,528,063 shares $209.54 million -5.2%9.1%6.55 $10.73
9/30/202620,597,867 shares $207.09 million -14.9%9.6%5.67 $10.05
9/15/202624,206,749 shares $208.42 million +1.4%11.2%10.81 $8.61
8/31/202623,870,475 shares $224.14 million +5.2%11.1%13.86 $9.39
8/14/202622,683,647 shares $214.81 million +3.5%10.5%7.98 $9.47
7/31/202621,918,195 shares $185.43 million -8.8%9.8%8.83 $8.46
7/15/202624,031,512 shares $208.59 million -0.8%10.8%9.12 $8.68
6/30/202624,232,698 shares $202.83 million +13.9%10.9%5.81 $8.37
6/15/202621,280,060 shares $180.88 million +7.0%9.6%6.49 $8.50
5/29/202619,897,126 shares $158.78 million -0.5%8.9%6.03 $7.98
5/15/202619,994,416 shares $165.35 million -3.2%9.0%2.26 $8.27
4/30/202620,658,114 shares $211.75 million +7.0%9.0%3.22 $10.25
4/15/202619,306,519 shares $205.61 million -12.9%8.7%3.84 $10.65
3/31/202622,175,506 shares $199.80 million -14.1%10.0%1.64 $9.01
3/13/202625,826,838 shares $391.28 million +35.0%11.3%7.12 $15.15
2/27/202619,137,458 shares $297.97 million -9.1%8.6%5.72 $15.57
2/13/202621,049,574 shares $338.69 million +8.3%9.5%11.75 $16.09
1/30/202619,439,065 shares $336.30 million +4.7%8.5%9.19 $17.30
1/15/202618,573,160 shares $325.03 million -2.1%8.1%7.22 $17.50
12/31/202518,972,317 shares $346.06 million +0.8%8.3%9.32 $18.24
12/15/202518,829,424 shares $371.50 million +1.4%8.2%7.26 $19.73
11/28/202518,563,031 shares $366.25 million -0.4%8.1%5.87 $19.73
11/14/202518,629,225 shares $289.87 million +11.9%8.1%4 $15.56
10/31/202516,649,924 shares $257.74 million -5.2%7.2%5.55 $15.48
10/15/202517,560,000 shares $264.98 million +0.9%7.6%5.2 $15.09
9/30/202517,410,000 shares $255.23 million +10.6%N/A5.4 $14.66
9/15/202515,740,000 shares $240.82 million +5.1%N/A5 $15.30
8/31/202514,980,000 shares $258.55 million +0.1%6.5%4.6 $17.26
8/15/202514,960,000 shares $254.17 million +8.9%N/A5 $16.99
7/31/202513,740,000 shares $256.94 million -5.0%6.0%4.2 $18.70
7/15/202514,470,000 shares $260.17 million -10.9%N/A4.5 $17.98
6/30/202516,240,000 shares $295.73 million +17.6%7.0%4.6 $18.21
6/15/202513,810,000 shares $287.39 million -3.5%6.0%4 $20.81
5/31/202514,310,000 shares $285.77 million +7.4%6.3%4.1 $19.97
5/15/202513,330,000 shares $255.94 million +7.9%5.9%3.7 $19.20
4/30/202512,350,000 shares $293.93 million -6.9%N/A3.6 $23.80
4/15/202513,260,000 shares $293.71 million +2.3%5.8%4.4 $22.15
3/31/202512,960,000 shares $257.13 million -14.0%5.7%4.6 $19.84
3/15/202515,070,000 shares $277.74 million +5.9%6.6%5.6 $18.43
Your Copy is on Hold (Claim it now) (Ad)

James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel

Claim your copy of James Altucher's new Elon Musk report today.
2/28/202514,230,000 shares $233.23 million +3.6%6.3%5.8 $16.39
2/15/202513,740,000 shares $218.47 million +4.3%6.0%5.8 $15.90
1/31/202513,180,000 shares $212.86 million -2.6%N/A4.9 $16.15
1/15/202513,530,000 shares $226.09 million -0.7%N/A4.6 $16.71
12/31/202413,620,000 shares $233.58 million +11.8%N/A3.9 $17.15
12/15/202412,180,000 shares $226.43 million -5.7%N/A3.2 $18.59
11/30/202412,910,000 shares $259.62 million -9.3%N/A2.6 $20.11
11/15/202414,240,000 shares $271.13 million -6.3%N/A2.8 $19.04
10/31/202415,200,000 shares $247.91 million -5.4%N/A2.9 $16.31
10/15/202416,070,000 shares $266.44 million -5.9%N/A3.1 $16.58
9/30/202417,080,000 shares $341.43 million +37.5%N/A3.6 $19.99
9/15/202412,420,000 shares $224.68 million +30.7%N/A2.6 $18.09
8/31/20249,500,000 shares $164.45 million +5.3%N/A2.6 $17.31
8/15/20249,020,000 shares $158.66 million +3.1%N/A2.6 $17.59
7/31/20248,750,000 shares $107.45 million +5.7%N/A2.5 $12.28
7/15/20248,280,000 shares $110.87 million +13.9%N/A2.6 $13.39
6/30/20247,270,000 shares $81.28 million -23.0%N/A2.5 $11.18
6/15/20249,440,000 shares $100.35 million +2.5%N/A3.4 $10.63
5/31/20249,210,000 shares $87.96 million +9.1%N/A3.3 $9.55
5/15/20248,440,000 shares $76.80 million -3.2%N/A2.9 $9.10
4/30/20248,720,000 shares $56.85 million +7.5%N/A3.4 $6.52
4/15/20248,110,000 shares $48.50 million +11.3%N/A3.2 $5.98
3/31/20247,290,000 shares $48.11 million -8.8%N/A2.7 $6.60
3/15/20247,990,000 shares $47.86 million +18.9%N/A3 $5.99
2/29/20246,720,000 shares $36.02 million +9.3%N/A2.6 $5.36
2/15/20246,150,000 shares $33.21 million -10.1%N/A2.9 $5.40
1/31/20246,840,000 shares $35.50 million -14.8%N/A3.2 $5.19
1/15/20248,030,000 shares $40.07 million +19.0%N/A3.7 $4.99
12/31/20236,750,000 shares $30.51 million -13.6%N/A3.4 $4.52
12/15/20237,810,000 shares $32.80 million -10.2%N/A4.2 $4.20
11/30/20238,700,000 shares $32.19 million -6.3%N/A4.9 $3.70
11/15/20239,280,000 shares $35.26 million -3.1%N/A4.8 $3.80
10/31/20239,580,000 shares $32.38 million +3.9%N/A4.1 $3.38
10/15/20239,220,000 shares $29.60 million +3.3%N/A4.2 $3.21
9/30/20238,930,000 shares $31.97 million +2.8%N/A4.1 $3.58
9/15/20238,690,000 shares $32.41 million -1.9%N/A4.1 $3.73
8/31/20238,860,000 shares $34.11 million -1.7%N/A4 $3.85
8/15/20239,010,000 shares $40.91 million +8.4%N/A4.2 $4.54
7/31/20238,310,000 shares $34.49 million -2.4%N/A4.1 $4.15
7/15/20238,510,000 shares $30.38 million +2.7%N/A4.2 $3.57
6/30/20238,290,000 shares $30.59 million -19.8%N/A3.9 $3.69
6/15/202310,340,000 shares $41.26 million -1.2%N/A4.6 $3.99
5/31/202310,460,000 shares $42.57 million -6.4%N/A4.4 $4.07
5/15/202311,170,000 shares $46.80 million -1.2%N/A4.6 $4.19
4/30/202311,310,000 shares $37.89 million -2.8%N/A5.1 $3.35
4/15/202311,640,000 shares $37.02 million -6.8%N/A4.9 $3.18
3/31/202312,490,000 shares $41.34 million +14.4%N/A5.1 $3.31
3/15/202310,920,000 shares $34.18 million +0.8%N/A4.4 $3.13
2/28/202310,830,000 shares $38.45 million -6.2%N/A3.8 $3.55
2/15/202311,550,000 shares $41.35 million -9.7%N/A3.9 $3.58
Top Trader Reveals Stunning Black Friday Deal (Ad)

Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel

Get the Snapback Indicator for just $7 in the Black Friday sale today.
1/31/202312,790,000 shares $47.20 million +6.1%N/A3.8 $3.69
1/15/202312,050,000 shares $40.97 million -5.3%N/A3.7 $3.40
12/30/202212,720,000 shares $49.35 million +1.8%N/A4 $3.88
12/15/202212,500,000 shares $44.50 million -37.4%N/A3.7 $3.56
11/30/202219,980,000 shares $66.73 million -8.1%N/A6 $3.34
11/15/202221,740,000 shares $70.44 million -15.9%N/A7.2 $3.24
10/31/202225,860,000 shares $72.93 million +0.2%N/A9.1 $2.82
10/15/202225,820,000 shares $67.65 million -6.3%N/A9.5 $2.62
9/30/202227,560,000 shares $66.97 million +6.0%N/A10.4 $2.43
9/15/202225,990,000 shares $70.43 million -2.0%N/A9 $2.71
8/31/202226,520,000 shares $71.60 million -6.2%N/A9.8 $2.70
8/15/202228,270,000 shares $68.13 million -1.7%N/A10.7 $2.41
7/31/202228,760,000 shares $61.55 million +0.1%N/A11.1 $2.14
7/15/202228,730,000 shares $66.08 million +1.3%N/A10.2 $2.30
6/30/202228,360,000 shares $56.15 million +11.0%N/A9.8 $1.98
6/15/202225,540,000 shares $51.85 million +1.0%N/A8.1 $2.03
5/31/202225,300,000 shares $51.87 million +5.4%N/A9.3 $2.05
5/15/202224,010,000 shares $42.26 million +4.5%N/A9.2 $1.76
4/30/202222,980,000 shares $42.28 million +3.1%N/A9.1 $1.84
4/15/202222,300,000 shares $44.82 million +10.1%N/A9.3 $2.01
3/31/202220,250,000 shares $37.06 million +25.0%N/A8.8 $1.83
3/15/202216,200,000 shares $25.11 million +10.7%N/A8.2 $1.55
2/28/202214,640,000 shares $23.57 million +4.4%N/A7.4 $1.61
2/15/202214,020,000 shares $23.41 million +36.0%N/A7.2 $1.67
1/31/202210,310,000 shares $14.95 million +1.2%N/A4.6 $1.45
1/15/202210,190,000 shares $14.27 million -4.1%N/A4.5 $1.40
12/31/202110,620,000 shares $14.97 million +6.6%N/A4.1 $1.41
12/15/20219,960,000 shares $12.75 million -1.2%N/A4 $1.28
11/30/202110,080,000 shares $13.91 million -9.7%N/A4.1 $1.38

ADMA Short Interest - Frequently Asked Questions

Short interest is the volume of ADMA Biologics shares that have been sold short but have not yet been closed out or covered. As of October 30th, investors have sold 18,035,119 shares of ADMA short. 8.38% of ADMA Biologics' shares are currently sold short. Learn More on ADMA Biologics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADMA shares currently have a short interest ratio of 7.1. Learn More on ADMA Biologics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.38% of ADMA Biologics' floating shares are currently sold short.

ADMA Biologics saw a decrease in short interest since the prior report. As of October 30th, there was short interest totaling 18,035,119 shares, a decrease of 7.6% from the previous total of 19,528,063 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

8.38% of ADMA Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to ADMA Biologics: ACADIA Pharmaceuticals Inc. (6.54%), Allogene Therapeutics, Inc. (17.10%), Madrigal Pharmaceuticals, Inc. (11.16%), Protagonist Therapeutics, Inc. (16.69%), Krystal Biotech, Inc. (11.82%), Arrowhead Pharmaceuticals, Inc. (8.53%), Praxis Precision Medicines, Inc. (15.54%), Cytokinetics, Incorporated (13.21%), Abivax SA Sponsored ADR (4.70%), Alkermes plc (12.25%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling ADMA is an investing strategy that aims to generate trading profit from ADMA Biologics as its price is falling. ADMA shares are trading down $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ADMA Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADMA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADMA, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ADMA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:ADMA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners